Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer
- PMID: 7542622
- DOI: 10.1006/gyno.1995.1214
Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer
Abstract
Ovarian cancer cells disseminate by implanting onto the peritoneal mesothelial cell surface of the abdominal cavity. A common feature of these peritoneal implants is the presence of tumor cell invasion into the submesothelial extracellular matrix (ECM). In view of the important role of integrins in ECM recognition and cell migration, we were interested in defining the pattern of integrin expression and function in ovarian cancer cell lines and primary tissue samples. The beta 1 integrin chain was expressed by CAOV-3, SKOV-3, OVCAR-3, and SW626 ovarian cancer cell lines, associated with expression of alpha 1, -2, -3, -5, and -6 chains. The alpha 4 chain was also expressed by two of the four lines. In addition to beta 1 integrins, the alpha v beta 3 integrin was also expressed, although there was no expression of beta 2, -4, and -7 chains. Immunoprecipitation of surface-labeled CAOV-3 cells with an anti-beta 1 antibody revealed a band at approximately 110-130 kDa consistent with the known molecular mass of the beta 1 chain, as well as several associated bands consistent with noncovalently linked integrin alpha chains. A similar pattern of beta 1 and alpha v beta 3 integrin expression was observed for primary ovarian cancer tissue samples. Ovarian cancer cell lines exhibited significant binding to collagen type I and laminin which was primarily mediated by beta 1 integrins. In contrast, ovarian cancer cell binding to fibronectin was mediated by both alpha 5 beta 1 and alpha v beta 3 integrins. Even though mesothelial cells were observed to express fibronectin mRNA and protein, binding of ovarian cancer cells to peritoneal mesothelium was not blocked by neutralizing antibodies to beta 1 or alpha v beta 3 integrins. These data suggest that functional integrins are commonly expressed by ovarian cancer cells, although they do not appear to mediate ovarian cancer cell implantation onto peritoneal mesothelium. The role that integrins play in the invasion of ovarian cancer cells into the submesothelial ECM deserves further investigation.
Similar articles
-
Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro.Gynecol Oncol. 1999 Jun;73(3):362-7. doi: 10.1006/gyno.1999.5388. Gynecol Oncol. 1999. PMID: 10366461
-
Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.Cancer Res. 1993 Aug 15;53(16):3830-8. Cancer Res. 1993. PMID: 8339295
-
Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.Gynecol Oncol. 2003 Apr;89(1):60-72. doi: 10.1016/s0090-8258(02)00152-x. Gynecol Oncol. 2003. PMID: 12694655
-
Integrin signaling and matrix assembly.Tumour Biol. 1996;17(2):117-24. doi: 10.1159/000217975. Tumour Biol. 1996. PMID: 8658014 Review.
-
Integrins: cell adhesives and modulators of cell function.Histochem J. 1993 Jul;25(7):469-77. doi: 10.1007/BF00159282. Histochem J. 1993. PMID: 8407358 Review.
Cited by
-
Differential effects of cellular fibronectin and plasma fibronectin on ovarian cancer cell adhesion, migration, and invasion.In Vitro Cell Dev Biol Anim. 2003 Mar-Apr;39(3-4):178-82. doi: 10.1007/s11626-003-0013-0. In Vitro Cell Dev Biol Anim. 2003. PMID: 14505428
-
Fluorescence-guided surgery for cancer patients: a proof of concept study on human xenografts in mice and spontaneous tumors in pets.Oncotarget. 2017 Nov 30;8(65):109559-109574. doi: 10.18632/oncotarget.22728. eCollection 2017 Dec 12. Oncotarget. 2017. PMID: 29312629 Free PMC article.
-
Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.Clin Exp Metastasis. 2005;22(5):391-402. doi: 10.1007/s10585-005-1262-y. Clin Exp Metastasis. 2005. PMID: 16283482
-
Peritoneal Carcinomatosis Targeting with Tumor Homing Peptides.Molecules. 2018 May 16;23(5):1190. doi: 10.3390/molecules23051190. Molecules. 2018. PMID: 29772690 Free PMC article. Review.
-
Oncolytic virotherapy for ovarian cancer.Oncolytic Virother. 2012 Aug;1:1-21. doi: 10.2147/ov.s31626. Oncolytic Virother. 2012. PMID: 25977900 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical